These infiltrating immune cells grant cancer cells immune escape mechanisms to diverge away from CD8+ T cells or NK cell/T-cell-mediated killing, enhancing the ability of cancer cells to acquire novel mutations, to evolve and to rapidly grow6. This evidence concerns the gene CD8A and cancer.